A detailed history of Bank Of America Corp transactions in Novartis Ag stock. As of the latest transaction made, Bank Of America Corp holds 4,888,193 shares of NVS stock, worth $504 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,888,193
Previous 5,147,666 5.04%
Holding current value
$504 Million
Previous $520 Million 9.03%
% of portfolio
0.04%
Previous 0.05%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $24.7 Million - $28.1 Million
-259,473 Reduced 5.04%
4,888,193 $473 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $14.1 Million - $15.5 Million
152,681 Added 3.06%
5,147,666 $520 Million
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $241 Million - $274 Million
-2,609,696 Reduced 34.32%
4,994,985 $504 Million
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $98.9 Million - $115 Million
1,235,303 Added 19.39%
7,604,681 $700 Million
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $64.1 Million - $78.4 Million
-847,796 Reduced 11.75%
6,369,378 $578 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $15.5 Million - $18.1 Million
-207,077 Reduced 2.79%
7,217,174 $549 Million
Q2 2022

Aug 12, 2022

SELL
$80.52 - $93.75 $35.5 Million - $41.4 Million
-441,484 Reduced 5.61%
7,424,251 $628 Million
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $6.2 Million - $7.02 Million
77,437 Added 0.99%
7,865,735 $690 Million
Q4 2021

Feb 08, 2022

SELL
$79.7 - $88.13 $114 Million - $126 Million
-1,424,172 Reduced 15.46%
7,788,298 $681 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $17.2 Million - $20.1 Million
210,828 Added 2.34%
9,212,470 $753 Million
Q2 2021

Sep 13, 2021

BUY
$85.24 - $94.15 $767 Million - $848 Million
9,001,642 New
9,001,642 $821 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.